Oriental Semi(688261)
Search documents
东微半导现2笔大宗交易 均为折价成交
Zheng Quan Shi Bao Wang· 2025-09-02 15:29
Summary of Key Points Core Viewpoint - Dongwei Semiconductor experienced significant trading activity on September 2, with a total of 73,000 shares traded at a total value of 5.2743 million yuan, reflecting a discount of 12% compared to the closing price of 82.10 yuan on the same day [2][3]. Trading Activity - The stock had a closing price of 82.10 yuan, down 1.56% for the day, with a turnover rate of 6.36% and a total trading volume of 636 million yuan [2]. - The net inflow of main funds for the day was 16.6668 million yuan, and the stock has seen a cumulative increase of 12.79% over the past five days, with a total net inflow of 147 million yuan during that period [2]. Margin Financing - The latest margin financing balance for Dongwei Semiconductor is 577 million yuan, which has increased by 119 million yuan over the past five days, representing a growth rate of 26.01% [3]. Block Trade Details - On September 2, two block trades were recorded, with the following details: - Trade 1: 43,000 shares at 3.1068 million yuan, priced at 72.25 yuan, with a discount of 12% [3]. - Trade 2: 30,000 shares at 2.1675 million yuan, also priced at 72.25 yuan, with a similar discount of 12% [3]. Buyer and Seller Information - Both trades were facilitated by CITIC Securities, with the buyer being the main CITIC Securities office and the seller being the Suzhou branch [3].
东微半导9月2日现2笔大宗交易 总成交金额527.43万元 溢价率为-12.00%
Xin Lang Cai Jing· 2025-09-02 10:10
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 9月2日,东微半导收跌1.56%,收盘价为82.10元,发生2笔大宗交易,合计成交量7.3万股,成交金额 527.43万元。 第1笔成交价格为72.25元,成交4.30万股,成交金额310.68万元,溢价率为-12.00%,买方营业部为中信 证券股份有限公司总部(非营业场所),卖方营业部为中信证券股份有限公司苏州分公司。 第2笔成交价格为72.25元,成交3.00万股,成交金额216.75万元,溢价率为-12.00%,买方营业部为中信 证券股份有限公司上海分公司,卖方营业部为中信证券股份有限公司苏州分公司。 进一步统计,近3个月内该股累计发生2笔大宗交易,合计成交金额为527.43万元。该股近5个交易日累 计上涨12.79%,主力资金合计净流入1.18亿元。 责任编辑:小浪快报 ...
东微半导今日大宗交易折价成交7.3万股,成交额527.43万元
Xin Lang Cai Jing· 2025-09-02 09:34
9月2日,东微半导大宗交易成交7.3万股,成交额527.43万元,占当日总成交额的0.82%,成交价72.25 元,较市场收盘价82.1元折价12%。 | 交易日期 | 还有简称 | 证券代码 | | | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | 美出精变部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-09-02 | 东徽学导 | 688261 | 72.25 | 310.68 | 4.3 | 中信证券股份有限 公司总部(非営业 场所) | 中信证券股份有限 公司苏州分公司 | 199 | | 2025-09-02 | 东微半导 | 688261 | 72.25 | 216.75 | | 中信证券股份有限 公司上海分公司 | 中信证券股份有限 公司苏州分公司 | 종 | ...
半导体板块持续走高
Di Yi Cai Jing· 2025-09-01 03:56
Group 1 - The core viewpoint of the article highlights significant stock price increases for several technology companies, indicating a positive market sentiment in the semiconductor sector [1] Group 2 - Yuanjie Technology and Liyang Chip both reached a 20% limit up in stock price [1] - Huahong Company saw an increase of over 16% in its stock price [1] - Other companies such as Guoxin Technology, Dongwei Semiconductor, Canxin Technology, and Zhaoyi Innovation also experienced notable stock price rises [1]
半导体板块再度上扬,源杰科技20cm涨停





Xin Lang Cai Jing· 2025-09-01 03:27
Group 1 - The semiconductor sector has seen a significant rise, with companies such as Source Technology and Liyang Chip hitting the daily limit of a 20% increase [1] - Huahong Company experienced a surge of over 14% in its stock price [1] - Other companies including Guoxin Technology, Dongwei Semiconductor, Canxin Technology, and Zhaoyi Innovation also showed upward trends in their stock prices [1]
华泰证券今日早参-20250901
HTSC· 2025-09-01 02:17
Macro Insights - The recent appreciation of the Renminbi against the US dollar and a basket of currencies has been notable, with a 0.4% increase observed on August 28-29 [2] - The manufacturing PMI for August showed a slight recovery to 49.4% from 49.3% in July, indicating marginal improvement in manufacturing activity [3] - The non-manufacturing business activity index rose to 50.3% from 50.1% in July, suggesting a stable outlook for the service sector [3] Investment Strategy - The technology sector is experiencing increased investor interest, with TMT transaction volume exceeding 40% of total market activity, indicating a shift towards fundamental-driven market behavior [5] - The report suggests focusing on sectors benefiting from Renminbi appreciation, such as consumption, non-bank financials, and electric new energy, which are currently at relatively low valuations [5] - The report emphasizes the importance of maintaining flexibility in investment strategies, particularly in the context of market volatility and sector rotation [8] Company Performance - Alibaba's Q1 FY26 revenue reached 247.7 billion yuan, a year-on-year increase of 1.8%, with adjusted EBITA declining by 13.7% [14] - Huichuan Technology reported a 26.73% increase in revenue for H1 2025, reaching 20.509 billion yuan, with a net profit of 2.968 billion yuan, up 40.15% [18] - Zhonggu Logistics experienced a 41.6% increase in net profit for H1 2025, despite a 7.0% decline in revenue, attributed to high demand in the foreign trade container leasing market [19] Sector Analysis - The beverage sector showed strong sales performance, with revenue growth of 22.8% in Q2 2025, while the snack food sector faced challenges with a 0.3% decline [12] - The insurance sector is seeing a shift towards high-yield stocks, with the average allocation to FVOCI stocks increasing by 1.3 percentage points to 4.2% [10] - The real estate sector is under pressure, with China Overseas Development reporting a 4% decline in revenue for H1 2025, but maintaining a strong project pipeline for future growth [22]
【私募调研记录】同犇投资调研迈瑞医疗、泽璟制药等3只个股(附名单)
Zheng Quan Zhi Xing· 2025-09-01 00:08
Group 1: Company Highlights - Mindray Medical has launched the world's first clinically implemented critical care large model, named Qiyuan Critical Care Model, and established a subsidiary for animal healthcare [1] - In the field of medical imaging, Mindray's "Ruiying Cloud++" has partnered with DeepSeek to officially release the "Ruiying·AI+" solution [1] - Zai Lab achieved a revenue of 376 million yuan in the first half of 2025, representing a year-on-year growth of 56%, driven by increased drug sales [1] - Zai Lab's recombinant human thrombin has been included in medical insurance, boosting sales, and the company is advancing multiple clinical trials for various tumors [1] - Zai Lab's NDA for Jikaxitini tablets for severe alopecia has been accepted, and several Phase III trials in the autoimmune field are under observation [1] - Dia Group reported a revenue of 786 million yuan in the first half of 2025, a year-on-year increase of 0.97%, with a net profit of 76 million yuan, up 131.61% [2] - The average sales of upgraded stores in the red gold theme have increased by approximately 36% year-on-year [2] - Dia Group plans to implement an equity incentive plan annually over four years and is expanding its presence in overseas markets, particularly in Paris and the U.S. [2] Group 2: Institutional Overview - Tongxin Investment, established in January 2014, is a distinctive sunshine private equity firm with a registered capital of 10 million yuan [3] - The firm is recognized for being one of the few sunshine private equity firms founded by top analysts from New Fortune and has a strong focus on consumer investment [3]
东微半导(688261.SH):2025年中报净利润为2758.14万元
Xin Lang Cai Jing· 2025-08-29 01:33
Group 1 - The company's total revenue for the first half of 2025 is 616 million yuan, ranking 80th among disclosed peers [1] - The net profit attributable to shareholders is 27.58 million yuan, ranking 82nd among disclosed peers [1] - The net cash flow from operating activities is -183 million yuan, ranking 127th among disclosed peers, a decrease of 159 million yuan compared to the same period last year [1] Group 2 - The company's latest debt-to-asset ratio is 6.56%, an increase of 0.64 percentage points compared to the same period last year [3] - The latest gross profit margin is 16.00%, ranking 121st among disclosed peers [3] - The latest return on equity (ROE) is 0.94%, ranking 89th among disclosed peers [3] - The diluted earnings per share is 0.23 yuan [3] Group 3 - The company's latest total asset turnover ratio is 0.20 times [4] - The latest inventory turnover ratio is 1.26 times [4]
苏州东微半导体股份有限公司 2025年半年度募集资金存放 与实际使用情况的专项报告
Zheng Quan Ri Bao· 2025-08-28 23:30
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688261 证券简称:东微半导 公告编号:2025-039 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律监管指引第1号——规范运 作》《上海证券交易所科创板股票上市规则》等有关法律、法规及相关文件的规定,苏州东微半导体股 份有限公司(以下简称"公司")编制了《2025年半年度募集资金存放与实际使用情况的专项报告》,具 体内容如下: 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意苏州东微半导体股份有限公司首次公开发行股票注册的批复》 (证监许可〔2021〕4040号),同意公司首次公开发行股票的注册申请。并经上海证券交易所同意,公 司首次向社会公众公开发行人民币普通股(A股)股票16,844,092股,本次发行价格为每股人民币130.00 元,募集资金总额为人民币2,189,731,960.00元,扣除保荐承销费155,127,216.60元(不 ...
东微半导:2025年第二季度,公司合并报表口径计提信用减值损失和资产减值损失约1121万元
Mei Ri Jing Ji Xin Wen· 2025-08-28 16:42
Group 1 - The company Dongwei Semiconductor (SH 688261) announced on August 29 that it will recognize credit impairment losses and asset impairment losses of approximately 11.21 million yuan in the second quarter of 2025, which will impact the total profit of the consolidated financial statements by the same amount [1] - For the fiscal year 2024, the company's revenue composition is as follows: integrated circuits account for 99.94%, while other businesses account for 0.06% [1]